HRH3 and early-onset autosomal dominant Alzheimer disease: H3R antagonists can be potential therapeutic agents for treating memory impairments and hyperactivity as H3R were previously targeted for Alzheimer’s disease and attention deficit hyperactivity disorder (ADHD) treatment [22,41,44,45].